Cancer Therapy
L-asparaginase may indicate chemotherapy dose changes for obese children with ALL
Published in Clinical Oncology Week, February 6th, 2006
"The objective of the current study was to compare chemotherapy dose modifications in obese (a body mass index [BMI] >95%) and nonobese (a BMI: 95%) pediatric patients with acute lymphoblastic leukemia (ALL). The study cohort was comprised of 199 pediatric patients diagnosed with ALL who were treated at 1 of 2 South Texas pediatric oncology centers between 1990-2000," scientists in the United States report.
J. Baillargeon and colleagues at the University of Texas explained, "The relative chemotherapy dose modification during the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
More Articles from Clinical Oncology Week
- Breast Cancer
Outcome after preoperative chemotherapy for breast cancer predicted by nomogram - Esophageal Cancer
Esophagectomy is the principle therapeutic option for squamous cell esophageal cancer - Hemangiopericytomas
Precision radiotherapy used in hemangiopericytomas of the central nervous system - Hodgkin Disease
Combined-modality therapy resulted in local control of Hodgkin Disease - Acute Myeloid Leukemia
PAF-R presence on surface of leukemic cells not detected by flow cytometry - Adenocarcinomas
COX-2 is expressed in stromal myofibroblasts surrounding colon adenocarcinomas - More from this issue of Clinical Oncology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
